Showing results (61-70 of 67) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
JTO Clinical and Research Reports|November 29, 2023
Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant ChemotherapyJunko Tanizaki, Hiroaki Kuroda, Toshihide Yokoyama, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2023
Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE)Koji Haratani, Atsushi Nakamura, Nobuaki Mamesaya, et al.British Journal of Cancer|March 23, 2024
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancerKoji Haratani, Atsushi Nakamura, Nobuaki Mamesaya, et al.Lung Cancer (Auckland, N.Z.)|June 28, 2024
Top 20 <i>EGFR+</i> NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating <i>EGFR</i> Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus SurveySai-Hong Ignatius Ou, Xiuning Le, Misako Nagasaka, et al.The Journal of Clinical Investigation|April 1, 2024
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockadeHidetoshi Hayashi, Kenji Chamoto, Ryusuke Hatae, et al.Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.JTO Clinical and Research Reports|September 30, 2021
Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With <i>EGFR</i> MutationsKiichiro Ninomiya, Shunsuke Teraoka, Yoshitaka Zenke, et al.Pageof 7